 The movement for a national pharmacare plan in Canada has gained momentum, despite opposition from multinational pharmaceutical companies and their supporters. These opponents argue that existing private insurance plans should be expanded to cover more drugs, that Canada cannot afford pharmacare, and that a national pharmacare program would be inferior to private plans. However, this commentary argues that none of these claims valid and that it is time to implement pharmacare.